A genetic determinant that specifically regulates the frequency of hematopoietic stem cells

被引:79
作者
Morrison, SJ
Qian, D
Jerabek, L
Thiel, BA
Park, IK
Ford, PS
Kiel, MJ
Schork, NJ
Weissman, IL
Clarke, MF
机构
[1] Univ Michigan, Dept Internal Med, Comprehen Canc Geriatr Ctr 4310, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA
[4] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA
[5] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA
[6] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA
[7] Case Western Reserve Univ, Ctr Human Genet, Cleveland, OH 44106 USA
关键词
D O I
10.4049/jimmunol.168.2.635
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The regulation of hematopoietic stem cell (HSC) homeostasis is not well understood. We screened for genetic polymorphisms that were linked to differences between mouse strains in the numbers of long-term reconstituting HSCs or restricted progenitors in the bone marrow. AKR/J nice had significantly higher frequencies and numbers of both HSCs and restricted progenitors in their bone marrow than C57BL/Ka-Thy-1.1 mice. The C57BL/Ka-Thy-1.1 alleles were partially dominant. A locus on chromosome 17, including the H-2 complex, was significantly linked to the frequency of long-term self-renewing HSCs but showed no evidence of linkage to the frequency of restricted progenitors. Conversely, a chromosome 1 locus exhibited suggestive linkage to restricted progenitor frequencies but was not linked to HSC frequency. This demonstrates that there are distinct genetic determinants of the frequencies of HSCs and restricted progenitors in vivo. The AKR/J chromosome 17 locus was not sufficient to increase HSC frequencies when bred onto a C57BL background. This suggests that to affect HSC frequencies, the product(s) of this locus likely depend on interactions with unlinked modifying loci.
引用
收藏
页码:635 / 642
页数:8
相关论文
共 68 条
[41]   Hematopoietic stem cells: Challenges to expectations [J].
Morrison, SJ ;
Wright, DE ;
Cheshier, SH ;
Weissman, IL .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (02) :216-221
[42]  
MORRISON SJ, 1996, NAT MED, V2, P202
[43]   Genetic control of the frequency of hematopoietic stem cells in mice: Mapping of a candidate locus to chromosome 1 [J].
MullerSieburg, CE ;
Riblet, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :1141-1150
[44]   TRANSCRIPTION FACTOR GATA-2 IS EXPRESSED IN ERYTHROID, EARLY MYELOID, AND CD34+ HUMAN LEUKEMIA-DERIVED CELL-LINES [J].
NAGAI, T ;
HARIGAE, H ;
ISHIHARA, H ;
MOTOHASHI, H ;
MINEGISHI, N ;
TSUCHIYA, S ;
HAYASHI, N ;
GU, L ;
ANDRES, B ;
ENGEL, JD ;
YAMAMOTO, M .
BLOOD, 1994, 84 (04) :1074-1084
[45]   Defects in hemopoietic stem cell activity in Ikaros mutant mice [J].
Nichogiannopoulou, A ;
Trevisan, M ;
Neben, S ;
Friedrich, C ;
Georgopoulos, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (09) :1201-1213
[46]   GENETIC-CONTROL OF MURINE HEMATOPOIETIC STEM-CELL POOL SIZES AND CYCLING KINETICS [J].
PHILLIPS, RL ;
REINHART, AJ ;
VANZANT, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (23) :11607-11611
[47]  
PLOEMACHER RE, 1991, BLOOD, V78, P2527
[48]   The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages [J].
Porcher, C ;
Swat, W ;
Rockwell, K ;
Fujiwara, Y ;
Alt, FW ;
Orkin, SH .
CELL, 1996, 86 (01) :47-57
[49]   FAILURE OF BLOOD-ISLAND FORMATION AND VASCULOGENESIS IN FLK-1-DEFICIENT MICE [J].
SHALABY, F ;
ROSSANT, J ;
YAMAGUCHI, TP ;
GERTSENSTEIN, M ;
WU, XF ;
BREITMAN, ML ;
SCHUH, AC .
NATURE, 1995, 376 (6535) :62-66
[50]  
Shizuru J A, 1996, Biol Blood Marrow Transplant, V2, P3